Cortexyme, Inc.
USD1.95
+0.05 (+2.63%)
CEO
Casey Lynch
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.91
Prev. Close
$1.90
Day Low
$1.86
Day High
$1.97
Market Cap
$0.07B
Volume
0.27M
| -1.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -36.9% | -17.4% | 0.16 | 8.09 | -1.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -51.4% | -49.7% | 0.00 | 30.55 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -75.8% | -67.5% | 0.01 | 7.85 | -4.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -44.6% | -40.6% | 0.00 | 8.11 | -10.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -32.0% | -29.7% | 0.00 | 11.93 | -28.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -17.5% | -17.1% | 0.00 | 49.82 | -56.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 60.3% | -158.5% | -0.35 | 4.28 | -57.9 |
| -1.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -1269.3% | -12.2% | 16.99 | 1.12 | -1.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -136.8% | -13.7% | 1.49 | 5.00 | -1.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -80.9% | -14.0% | 0.85 | 4.05 | -1.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -41.3% | -10.9% | 0.49 | 6.05 | -1.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -12.2% | -4.3% | 0.34 | 9.53 | -1.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -59.0% | -20.6% | 0.31 | 6.15 | -0.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.0% | -7.0% | 0.19 | 7.16 | -1.1 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -10.5% | -4.9% | 0.16 | 8.09 | -1.2 |